Rallybio (RLYB)
NASDAQ:RLYB
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 858.00K | $ 636.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 766.00K | $ 636.00K | $ -150.00K | $ -167.00K | $ -109.00K |
| Operating Income | $ -28.06M | $ -60.50M | $ -78.93M | $ -67.88M | $ -45.65M |
| EBITDA | $ -27.97M | $ -60.37M | $ -78.78M | $ -67.72M | $ -45.39M |
| Net Income | $ -8.98M | $ -57.77M | $ -74.56M | $ -66.65M | $ -47.01M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 54.74M | $ 65.51M | $ 109.93M | $ 168.99M | $ 175.33M |
| Total Assets | $ 62.26M | $ 68.11M | $ 115.62M | $ 180.44M | $ 182.19M |
| Total Debt | $ 176.00K | $ 154.00K | $ 392.00K | $ 555.00K | $ 0.00 |
| Net Debt | $ -31.20M | $ -13.75M | $ -24.10M | $ -56.40M | $ -175.33M |
| Total Liabilities | $ 4.30M | $ 6.45M | $ 9.44M | $ 11.12M | $ 6.58M |
| Stockholders' Equity | $ 57.96M | $ 61.65M | $ 106.18M | $ 169.32M | $ 175.60M |
| Cash Flow | |||||
| Free Cash Flow | $ -29.81M | $ -49.28M | $ -60.28M | $ -57.34M | $ -45.87M |
| Operating Cash Flow | $ -29.81M | $ -49.28M | $ -60.27M | $ -57.28M | $ -45.53M |
| Investing Cash Flow | $ 47.27M | $ 33.49M | $ 27.66M | $ -112.17M | $ -2.33M |
| Financing Cash Flow | $ 16.00K | $ 5.20M | $ 143.00K | $ 51.08M | $ 82.97M |